Tyler Rapp

Tyler Rapp

Auto-generated profile, based on publicly available information

Tyler Rapp

Institute of Global Health and Infectious Diseases, University of North Carolina School of Medicine

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 May 2024 in The Journal of Infectious Diseases
Verified
Journal Article
Closed access
TRTyler Rapp
Tyler Rapp
KAKano Amagai
Kano Amagai
CSCyrus Sinai
Cyrus Sinai
CBChristopher Basham
Christopher Basham
MLMwajabu Loya
Mwajabu Loya
JLJessica T Lin
Jessica T Lin
Background: Asymptomatic carriage of malaria parasites persists even as malaria transmission declines. Low-density infections are often submicroscopic, not detected with rapid diagnostic tests (RDTs) or microscopy but detectable by polymerase chain reaction (PCR). Methods: To characterize submicroscopic Plasmodium falciparum carriage in an area of declining malaria transmission, asymptomatic persons >5 years of age in rural Bagamoyo District, Tanzania, were screened using RDT, microscopy, and PCR. We investigated the size of the submicroscopic reservoir of infection across villages, determined factors associated with submicroscopic carriage, and assessed the natural history of submicroscopic malaria over 4 weeks. Results: Among 6076 participants, P. falciparum prevalences by RDT, microscopy, and PCR were 9%, 9%, and 28%, respectively, with roughly two-thirds of PCR-positive individuals harboring submicroscopic infection. Adult status, female sex, dry season months, screened windows, and bed net use were associated with submicroscopic carriage. Among 15 villages encompassing 80% of participants, the proportion of submicroscopic carriers increased with decreasing village-level malaria prevalence. Over 4 weeks, 23% of submicroscopic carriers (61 of 266) became RDT positive, with half exhibiting symptoms, while half (133 of 266) were no longer parasitemic at the end of 4 weeks. Progression to RDT-positive patent malaria occurred more frequently in villages with higher malaria prevalence. Conclusions: Microheterogeneity in transmission observed at the village level appears to affect both the size of the submicroscopic reservoir and the likelihood of submicroscopic carriers developing patent malaria in coastal Tanzania.

5 August 2022 in American Journal of Medical Genetics Part A
Verified
Journal Article
Closed access
TRTyler Rapp
Tyler Rapp
AKAllison J. Kalinousky
Allison J. Kalinousky
JJJennifer Johnson
Jennifer Johnson
HBHans Bjornsson
Hans Bjornsson
JHJacqueline Harris
Jacqueline Harris

10 September 2023 in medRxiv
Verified
Preprint
Open access
PDF file
TRTyler Rapp
Tyler Rapp
KAKano Amagai
Kano Amagai
CSCyrus Sinai
Cyrus Sinai
CBChristopher Basham
Christopher Basham
MLMwajabu Loya
Mwajabu Loya
JLJessica T. Lin
Jessica T. Lin
Background: Asymptomatic malaria may be patent (visible by microscopy) and detectable by rapid malaria diagnostic tests (RDTs), or it may be submicroscopic and only detectable by polymerase chain reaction (PCR). Methods: To characterize the submicroscopic reservoir in an area of declining malaria transmission, asymptomatic persons >5 years of age in Bagamoyo District, Tanzania, were screened using RDT, microscopy, and PCR. We investigated the size of the submicroscopic reservoir across villages, determined factors associated with submicroscopic parasitemia, and assessed the natural history of submicroscopic malaria over four weeks. Results: Among 6,076 participants, Plasmodium falciparum prevalence by RDT, microscopy, and PCR was 9%, 9%, and 28%, respectively, with roughly two-thirds of PCR-positive individuals harboring submicroscopic infection. Adult status, female gender, dry season months, screened windows, and bednet use were associated with submicroscopic carriage. Among 15 villages encompassing 80% of participants, the proportion of submicroscopic carriers increased with decreasing village-level malaria prevalence. Over four weeks, 23% (61/266) of submicroscopic carriers became RDT-positive and were treated, with half exhibiting symptoms. This occurred more frequently in villages with higher malaria prevalence. Conclusions: Micro-heterogeneity in transmission impacts the size of the submicroscopic reservoir and the likelihood of submicroscopic carriers developing patent malaria in coastal Tanzania.

29 October 2024 in medRxiv
Verified
Preprint
Open access
PDF file
MCMehal Churiwal
Mehal Churiwal
KTKathleen Tompkins
Kathleen Tompkins
GSGabrielle Streeter
Gabrielle Streeter
CLChristy Litel
Christy Litel
SMSydney Mason
Sydney Mason
JLJessica T. Lin
Jessica T. Lin
Background: Early in the SARS-CoV-2 pandemic, description of COVID-19 illness among non-hospitalized patients was limited. Data from household cohorts can help reveal the full spectrum of disease and the potential for long-term sequelae, even in non-severe disease. Methods: Daily symptom diaries were collected in a US household cohort of SARS-CoV-2 infection from April to November 2020, during the pre-COVID vaccine period. SARS-CoV-2 nasal viral loads were measured at study entry and weekly until day 21; serologic testing was performed at study entry and day 28. A subset of volunteers underwent an additional assessment 8-10 months later. Participants who met the criteria for early infection—testing antibody-negative at study entry but PCR-positive either at baseline or during follow-up—were included in this analysis (n=143). Results: Daily symptoms were ascertained in 143 outpatients with acute COVID-19, including 60 index cases who sought testing and 83 of their household contacts. Asymptomatic cases comprised 16% (13/83) of SARS-CoV-2 infections detected among household contacts. Among 119 persons with mild or moderate illness, the number of symptoms peaked 3 or 4 days after symptom onset. Fever and anosmia occurred in nearly half of participants. Symptom severity was associated with increased age, viral load, and cardiovascular disease. Increased BMI was associated with a higher antibody level at day 28, independent of symptom severity. Those with a higher day 28 antibody level were more likely to develop symptoms consistent with post-acute sequelae of SARS-CoV-2 (PASC), also known as long COVID-19, 8-10 months later. Conclusions: Fever, anosmia, as well as asymptomatic infection were common features of COVID-19 non-severe illness when the D614G variant circulated in the US, before the availability of vaccines or outpatient therapies. Antibody levels following acute infection were linked to the development of symptoms of PASC 8-10 months later.

13 July 2026 in Journal of Health Advocacy
Verified
Journal Article
Open access
TRTyler Rapp
Tyler Rapp
LWLaura Willing
Laura Willing
DDDanielle Dooley
Danielle Dooley
EIElizabeth Ireson
Elizabeth Ireson
DTDesiree de la Torre
Desiree de la Torre
ASAmanda Stewart
Amanda Stewart
Health outcomes and voting are inextricably linked, making healthcare spaces growing sites of opportunity for voter registration efforts. This case study of a comprehensive, nonpartisan voter registration effort at Children’s National, a large freestanding children’s hospital in Washington, D.C. and at its network of outpatient centers across D.C., Maryland, and Virginia, highlights why advocacy focused on voting is essential to health and healthcare. Using materials from Vot-ER and customized materials including physical flyers and voting guides incorporated into the electronic health record, our efforts resulted in the engagement of hundreds of eligible voters in inpatient and outpatient settings that can be used as a model by other healthcare systems. Lessons learned include the importance of collaborating with hospital leadership, starting efforts early, identifying voter registration champions, and understanding voting policies and regulations, especially in institutions serving patients and families from multiple voting jurisdictions. Our team advocates for more healthcare systems to participate in voter registration and mobilization efforts and support staff, patients, and families in voting. Our efforts to advocate for increased voter registration efforts within our healthcare system are aligned with our focus on child health, as we recognize that voter participation helps shape the policies and public investments that influence child and family health outcomes. Other advocates can adapt this model as a scalable framework for implementing voter registration initiatives across diverse healthcare systems and voting jurisdictions.

5 February 2026 in PLOS ONE
Verified
Journal Article
Open access
PDF file
MCMehal Churiwal
Mehal Churiwal
KTKathleen Tompkins
Kathleen Tompkins
GSGabrielle Streeter
Gabrielle Streeter
CLChristy Litel
Christy Litel
SMSydney Mason
Sydney Mason
JLJessica T. Lin
Jessica T. Lin
Background: Early in the SARS-CoV-2 pandemic, description of COVID-19 illness among non-hospitalized patients was limited. Data from household cohorts can help reveal the full spectrum of disease and the potential for long-term sequelae, even in non-severe disease. Methods: Daily symptom diaries were collected in a US household cohort of SARS-CoV-2 infection from April to November 2020, during the pre-COVID vaccine period. SARS-CoV-2 nasal viral loads were measured at study entry and weekly until day 21; serologic testing was performed at study entry and day 28. A subset of volunteers underwent an additional assessment 8–10 months later. Participants who met the criteria for early infection—testing antibody-negative at study entry but PCR-positive either at baseline or during follow-up—were included in this analysis (n = 143). Results: Daily symptoms were ascertained in 143 outpatients with acute COVID-19, including 60 index cases who sought testing and 83 of their household contacts. Asymptomatic cases comprised 16% (13/83) of SARS-CoV-2 infections detected among household contacts. Among 119 persons with mild or moderate illness, the number of symptoms peaked 3 or 4 days after symptom onset. Fever and anosmia occurred in nearly half of participants. Symptom severity was associated with increased age, viral load, and cardiovascular disease. Increased BMI was associated with a higher antibody level at day 28, independent of symptom severity. Those with a higher day 28 antibody level were more likely to develop symptoms consistent with post-acute sequelae of SARS-CoV-2 (PASC), also known as long COVID-19, 8–10 months later. Conclusions: Fever, anosmia, as well as asymptomatic infection were common features of COVID-19 non-severe illness when the D614G variant circulated in the US, before the availability of vaccines or outpatient therapies. Antibody levels following acute infection were linked to the development of symptoms of PASC 8–10 months later.